Back

prof. dr. R.E.G. Schutgens

prof. dr. R.E.G. Schutgens

Full Professor

Show full profile

Research Output (276)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Versloot Olav, Iserman Emma, Chelle Pierre, Germini Federico, Edginton Andrea N, Schutgens Roger E G, Iorio Alfonso, Fischer Kathelijn 21 Apr 2022, In: HemaSphere. 6 , p. 1-7

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease:a phase 2, open-label study

van Dijk Myrthe J, Rab Minke A E, van Oirschot Brigitte A, Bos Jennifer, Derichs Cleo, Rijneveld Anita W, Cnossen Marjon H, Nur Erfan, Biemond Bart J, Bartels Marije, Jans Judith J M, van Solinge Wouter W, Schutgens Roger E G, van Wijk Richard, van Beers Eduard J 5 Apr 2022, In: American Journal of Hematology. 97 , p. E226-E229

Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia

Noordermeer Tessa, van Asten Ivar, Schutgens Roger E.G., Lakerveld Anke J., Koekman Cornelis A., Hage Kay Y., Sebastian Silvie A.E., Huisman Albert, van den Heuvel Dave J., Gerritsen Hans C., Korporaal Suzanne J.A., Bierings Marc, van der Smagt Jasper J., van Gijn Marielle E., Urbanus Rolf T. 7 Mar 2022, In: Blood Advances. 6 , p. 3347-3351 5 p.

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT:To WiN study

Heijdra Jessica M., Al Arashi Wala, De Jager Nico C.B., Cloesmeijer Michael E., Bukkems Laura H., Zwaan Christian M., Leebeek Frank W.G., Mathôt Ron A.A., Cnossen Marjon H., Cnossen M. H., Leebeek F. W.G., Zwaan Christian M., Van Vliet I., Fijnvandraat K., Mathot R. A.A., Meijer K., Kruip M. J.H.A., S Polinder Polinder, Coppens M., Tamminga R. Y.J., Meijer K., Laros-Van B. A.P., Brons P., Schols S. E.M., Van Der Meer F. J.M., Eikenboom H. C.J., Schutgens R. E.G., Fischer K., Heubel-Moenen F., Nieuwenhuizen L., Ypma P., Driessens M. H.E., Pw Collins Collins, Liesner R., Chowdary P., Keeling D. 15 Feb 2022, In: BMJ Open. 12 , p. 1-6

LIVER-RELATED COMPLICATIONS DURING LONG-TERM HEPATITIS C VIRUS INFECTION AND AFTER SUCCESSFUL ANTIVIRAL TREATMENT IN PEOPLE WITH INHERITED BLEEDING DISORDERS

Isfordink C., van Erpecum K., Fischer K., van Vulpen L., Schutgens R., Arends J., Mauser-Bunschoten E. Feb 2022, In: Haemophilia. 28 , p. 18-18

Treatment of patients with rare bleeding disorders in the Netherlands:Real-life data from the RBiN study

Maas Dominique P M S M, Saes Joline L, Blijlevens Nicole M A, Cnossen Marjon H, den Exter Paul L, Kruis Ilmar C, Meijer Karina, Nieuwenhuizen Laurens, Peters Marjolein, Schutgens Roger E G, van Heerde Waander L, Schols Saskia E M, 17 Jan 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 833-844 12 p.

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

Goedhart Tine M H J, Bukkems Laura H, Coppens Michiel, Fijnvandraat Karin J, Schols Saskia E M, Schutgens Roger E G, Eikenboom Jeroen, Heubel-Moenen Floor C J I, Ypma Paula F, Nieuwenhuizen L, Meijer K, Leebeek Frank W G, Mathôt Ron A A, Cnossen Marjon H Jan 2022, In: TH open : companion journal to thrombosis and haemostasis. 6 , p. e60-e69

Relapse of immune thrombocytopenia after COVID-19 vaccination

van Dijk Wobke Else Maria, Schutgens Roger E G Jan 2022, In: European Journal of Haematology. 108 , p. 84-85 2 p.

Ankle joint distraction is a promising alternative treatment for patients with severe haemophilic ankle arthropathy

van Bergen Eline D.P., Mastbergen Simon C., Vogely H. Charles, Balani Tanya N., de Kleijn Piet, Foppen Wouter, van Roermund Peter M., Lafeber Floris P.J.G., Schutgens Roger E.G., van Vulpen Lize F.D. 2022, In: Haemophilia. 28 , p. 1044-1053 10 p.

Deep compartment models:A deep learning approach for the reliable prediction of time-series data in pharmacokinetic modeling

Janssen Alexander, Leebeek Frank W.G., Cnossen Marjon H., Mathôt Ron A.A., Fijnvandraat K., Coppens M., Meijer K., Schols S. E.M., Eikenboom H. C.J., Schutgens R. E.G., Beckers E. A.M., Ypma P., Kruip M. J.H.A., Polinder S., Tamminga R. Y.J., Brons P., Fischer K., van Galen K. P.M., Heubel-Moenen F. C.J.I., Nieuwenhuizen L., Driessens M. H.E., van Vliet I., Lock J., Hazendonk H. C.A.M., van Moort I., Heijdra J. M., Goedhart M. H.J., Al Arashi W., Preijers T., de Jager N. C.B., Bukkems L. H., Cloesmeijer M. E., Collins P. W., Liesner R., Chowdary P., Millar C. M., Hart D., Keeling D., 2022, In: CPT: Pharmacometrics and Systems Pharmacology. 11 , p. 934-945 12 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not